Rising ovarian cancer cases in India put focus on silent symptoms
Doctors are warning about a rise in ovarian cancer cases among Indian women as symptoms are often missed. The concern is growing because delayed diagnosis, weak awareness and lifestyle risks can worsen outcomes.

According to Globocan 2022 data, India recorded 47,333 ovarian cancer cases – malignancies that originate in the ovaries, fallopian tubes, or peritoneum (membrane lining the abdominal wall), making it the ninth most common cancer overall in the country.
The disease also caused 32,978 deaths, ranking tenth among all cancer-related deaths. Among Indian women, ovarian cancer is now the third most common malignancy after breast and cervical cancers.
Oncologists say the numbers reflect not only increasing incidence but also the challenge of detecting the disease early. Unlike breast cancer, which can often be identified through routine screening and self-examination, ovarian cancer usually develops silently and is discovered only in advanced stages.
Dr Poonam Maurya, senior medical oncologist at Apollo Hospitals in Bengaluru, said the disease is increasingly being diagnosed among urban Indian women, driven by multiple lifestyle and biological factors.
“This increase is probably due to changes in lifestyle, being overweight, having children later in life, trouble getting pregnant, endometriosis, hormones, smoking and genes.”
Doctors point out that women carrying BRCA1 and BRCA2 gene mutations, or those with a family history of ovarian and breast cancer, face significantly higher risks.
The Indian Council of Medical Research (ICMR) says that despite being less frequent than breast cancer, ovarian cancer is three times more deadly, and estimates indicate that by 2040, the death rate from ovarian cancer will have significantly increased.
Globally, India ranks second in ovarian cancer incidence, following China, and is responsible for 76.5 per cent of ovarian cancer cases and 77.5 per cent of deaths in South Central Asian nations.
The highest age-adjusted incidence rates per 1,00,000 population for this malignancy, as per the ICMR, were observed in Delhi at 9.5, Bengaluru at 9.4, Hyderabad at 9.2, Chennai at 8.9, and Bhopal at 7.9.
The incidence of ovarian cancer rises after the age of 35 and reaches its highest level between the ages of 55 and 64 years.
However, the larger challenge lies in the fact that symptoms are often mistaken for common health issues.
MISLEADING SIGNS
Bloating that refuses to go away, discomfort in the pelvic area, feeling unusually tired, getting full quickly after meals, or sudden changes in urination are among the early signs of ovarian cancer.
Yet these symptoms are so general that many women dismiss them as acidity, hormonal imbalance, stress, or digestive trouble.
Dr Ashwani Kumar Sharma, senior onco-surgeon with Manipal hospital in Gurugram, said the early signs are often deceptive.
“Ovarian cancer symptoms are often misleading in the early stages because they mimic common digestive or menstrual issues such as bloating, acidity, abdominal discomfort, frequent urination, or feeling early satiety post meals,” he explained.
“Since these symptoms are vague and occur irregularly, many women ignore them as hormonal changes, gastric problems, or lifestyle-related discomfort.”
The consequences of this confusion can be devastating. By the time many women seek medical attention, the cancer may already have spread beyond the ovaries, reducing survival rates and complicating treatment.
Doctors say younger women, in particular, tend to ignore persistent symptoms because they do not associate them with cancer.
“Unlike breast cancer, ovarian cancer does not have a good test to screen the whole population,” Dr Maurya said. “So being aware and getting medical help on time is crucial.”
Experts stress that symptoms persisting for several weeks should never be ignored.
Persistent bloating, pelvic or abdominal pain, difficulty eating, unexplained weight changes, and frequent urination are all warning signs that deserve medical evaluation.
DELAYS TURN DEADLY
Another major problem, specialists say, is the tendency to self-medicate or normalise discomfort. Women often treat symptoms with home remedies or over-the-counter medicines instead of seeking professional advice.
According to Dr Anand Mohan, surgical oncologist with CK Birla Hospitals in Jaipur, many patients arrive at hospitals only after months of unexplained discomfort.
He added that the location of the ovaries inside the abdomen makes early diagnosis even harder. “Ovaries being organs hidden inside the abdomen makes early diagnosis next to impossible,” he said.
The emotional burden of delayed diagnosis is equally severe. Women balancing careers, caregiving responsibilities, and household duties often push their own health concerns aside.
Social conditioning also plays a role, with many women taught to tolerate pain and discomfort quietly.
For these reasons, health experts are now calling for stronger awareness campaigns focused specifically on gynaecological cancers. They argue that public messaging around ovarian cancer remains far weaker compared to breast cancer awareness drives.
At the same time, advances in treatment are offering new hope. Modern surgical techniques, improved chemotherapy protocols, targeted therapies, and personalised medicine are significantly improving outcomes for many patients. Genetic testing is also helping identify women at high risk earlier than before.
Regular gynaecological check-ups, timely imaging tests, and attention to family history can make a critical difference, specialists say.
According to Globocan 2022 data, India recorded 47,333 ovarian cancer cases – malignancies that originate in the ovaries, fallopian tubes, or peritoneum (membrane lining the abdominal wall), making it the ninth most common cancer overall in the country.
The disease also caused 32,978 deaths, ranking tenth among all cancer-related deaths. Among Indian women, ovarian cancer is now the third most common malignancy after breast and cervical cancers.
Oncologists say the numbers reflect not only increasing incidence but also the challenge of detecting the disease early. Unlike breast cancer, which can often be identified through routine screening and self-examination, ovarian cancer usually develops silently and is discovered only in advanced stages.
Dr Poonam Maurya, senior medical oncologist at Apollo Hospitals in Bengaluru, said the disease is increasingly being diagnosed among urban Indian women, driven by multiple lifestyle and biological factors.
“This increase is probably due to changes in lifestyle, being overweight, having children later in life, trouble getting pregnant, endometriosis, hormones, smoking and genes.”
Doctors point out that women carrying BRCA1 and BRCA2 gene mutations, or those with a family history of ovarian and breast cancer, face significantly higher risks.
The Indian Council of Medical Research (ICMR) says that despite being less frequent than breast cancer, ovarian cancer is three times more deadly, and estimates indicate that by 2040, the death rate from ovarian cancer will have significantly increased.
Globally, India ranks second in ovarian cancer incidence, following China, and is responsible for 76.5 per cent of ovarian cancer cases and 77.5 per cent of deaths in South Central Asian nations.
The highest age-adjusted incidence rates per 1,00,000 population for this malignancy, as per the ICMR, were observed in Delhi at 9.5, Bengaluru at 9.4, Hyderabad at 9.2, Chennai at 8.9, and Bhopal at 7.9.
The incidence of ovarian cancer rises after the age of 35 and reaches its highest level between the ages of 55 and 64 years.
However, the larger challenge lies in the fact that symptoms are often mistaken for common health issues.
MISLEADING SIGNS
Bloating that refuses to go away, discomfort in the pelvic area, feeling unusually tired, getting full quickly after meals, or sudden changes in urination are among the early signs of ovarian cancer.
Yet these symptoms are so general that many women dismiss them as acidity, hormonal imbalance, stress, or digestive trouble.
Dr Ashwani Kumar Sharma, senior onco-surgeon with Manipal hospital in Gurugram, said the early signs are often deceptive.
“Ovarian cancer symptoms are often misleading in the early stages because they mimic common digestive or menstrual issues such as bloating, acidity, abdominal discomfort, frequent urination, or feeling early satiety post meals,” he explained.
“Since these symptoms are vague and occur irregularly, many women ignore them as hormonal changes, gastric problems, or lifestyle-related discomfort.”
The consequences of this confusion can be devastating. By the time many women seek medical attention, the cancer may already have spread beyond the ovaries, reducing survival rates and complicating treatment.
Doctors say younger women, in particular, tend to ignore persistent symptoms because they do not associate them with cancer.
“Unlike breast cancer, ovarian cancer does not have a good test to screen the whole population,” Dr Maurya said. “So being aware and getting medical help on time is crucial.”
Experts stress that symptoms persisting for several weeks should never be ignored.
Persistent bloating, pelvic or abdominal pain, difficulty eating, unexplained weight changes, and frequent urination are all warning signs that deserve medical evaluation.
DELAYS TURN DEADLY
Another major problem, specialists say, is the tendency to self-medicate or normalise discomfort. Women often treat symptoms with home remedies or over-the-counter medicines instead of seeking professional advice.
According to Dr Anand Mohan, surgical oncologist with CK Birla Hospitals in Jaipur, many patients arrive at hospitals only after months of unexplained discomfort.
He added that the location of the ovaries inside the abdomen makes early diagnosis even harder. “Ovaries being organs hidden inside the abdomen makes early diagnosis next to impossible,” he said.
The emotional burden of delayed diagnosis is equally severe. Women balancing careers, caregiving responsibilities, and household duties often push their own health concerns aside.
Social conditioning also plays a role, with many women taught to tolerate pain and discomfort quietly.
For these reasons, health experts are now calling for stronger awareness campaigns focused specifically on gynaecological cancers. They argue that public messaging around ovarian cancer remains far weaker compared to breast cancer awareness drives.
At the same time, advances in treatment are offering new hope. Modern surgical techniques, improved chemotherapy protocols, targeted therapies, and personalised medicine are significantly improving outcomes for many patients. Genetic testing is also helping identify women at high risk earlier than before.
Regular gynaecological check-ups, timely imaging tests, and attention to family history can make a critical difference, specialists say.